Because KeyStone is truly an independent research advisory firm. This should not make us unique, but it does. Unlike the big banks and brokerages, we do not perform financing for the stocks we recommend and do not receive payment from companies for their inclusion within our research. This focusses us on one thing, finding the best performing stocks for investors across North America! 

Make 2021 the year you take control of your portfolio, pay less fees and let KeyStone show you how to create a simple portfolio of 15-25 quality growth and dividend growth stocks designed to grow your wealth long-term.

Don’t settle with paying high fees and continually underperforming the market. Join the thousands of Canadians like you who have taken control of their stock portfolios with a simple strategy that allows you to pay less fees and create a quality 15-25 stock portfolio. It’s your money and your financial future, so do something about it!

If you are looking for the magic button to financial freedom, look elsewhere. What we provide is solid, practical advice with real time tested recommendations and a simple ongoing strategy. We do not believe in hype. Our goal is to keep it simple and recommend buying great businesses. Our research, paired with a low-cost discount broker helps you create a simple portfolio of between 15-25 stocks designed to beat the market long-term.

Our analysts are always on the hunt for the next great stock to recommend to clients. Just take a look at KeyStone’s 2019 & 2020 World Outlook Financial Conference Recommendations below, returning clients 185% and 42% respectively.

If you would have purchased just the small-cap portfolio from KeyStone’s 2020 WOFC Recommendations, which included Viemed, Sylogist, Enghouse and Dynacor – you would have made a gain of over 36% in just one year!

Remember, KeyStone’s clients gained access to these great cash producing businesses at significantly lower prices. Such as XPEL (XPEL:NASDAQ) at $1.43, Sangoma (STC:TSX-V) at just $0.72, Boyd (BYD:TSX) at $2.30, Viemed (VMD:TSX) at $3.85, and many more at significantly lower prices. Don’t miss out, become a client and get KeyStone’s portfolio changing recommendations before the rest of the market!

And in 2019, if you would have purchased the small-cap portfolio from KeyStone’s 2019 WOFC Recommendations you would have gained over 236% in just two years! Propelled by XPEL (XPEL:NASDAQ), a game changing recommendation for anyones portfolio.

ALL new clients will receive at least 2 of the following Bonus Reports for no additional charge;

Upcoming Reports:  2021 U.S. Dividend Growth Stock Report, 2021 Canadian Cash Rich, Profitable Growth Stock Report, 2021 Canadian Dividend All Star Report, & 2021 Breakthrough/Turnaround Canadian Small-Cap Report ($599 each).

Immediate Access: 2020 U.S. Cash Rich, Profitable Growth Stock Report, KeyStone’s 2020 Canadian Green/Alternative Energy Stock Report, KeyStone’s 2020 Cannabis Report, & U.S. Profitable Small & Micro-Cap Growth Special Report ($599 each).

***VIP Clients receive access to ALL Special Reports!*** 

Gain access to all of KeyStone’s research with our VIP Membership, tailored to investors who want to build a portfolio of 15-25 stocks encompassing our diverse landscape of high-quality Canadian Growth & Dividend Stocks, U.S. Growth/Value Stocks and Dividend Growth Stocks.

Including our Simple Portfolio Builder Tool which guides clients in their portfolio building journey by indicating to them how many stocks to hold and which stocks are KeyStone’s highest conviction buy recommendations to potentially add to their portfolio next.

1. How many stocks to buy and in what dollar amount.
2. What 5-6 stocks to start with.
3. Which 2-3 stocks to add each quarter over the next 12-24 months.